Federal award
MAPP BIOPHARMACEUTICAL, INC.
W81XWH21C0121
Contract
Obligated and Ceiling
- Obligated (net)
- $601,141.85
- Ceiling (potential value, not spending)
- $1,192,803.19
- Current value
- $767,803.19
- Gross positive obligations
- $700,416.72
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- MAPP BIOPHARMACEUTICAL, INC. · M9V9QTHR1H28
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- MAPP BIOPHARMACEUTICAL, INC. · M9V9QTHR1H28
- Awarding agency
- Department of War · sub-agency 97DH · office HT9425
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- AN13 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
- Industry (NAICS)
- 541380 · TESTING LABORATORIES AND SERVICES
- PIID
- W81XWH21C0121
- Award type code
- D
- Actions
- 7 · Sep 24, 2021 to Jul 31, 2024
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History7
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jul 31, 2024 | FY2024 | P00006 | C | −$9,696.81 | — |
| Nov 9, 2023 | FY2024 | P00005 | C | −$89,578.06 | — |
| Mar 1, 2023 | FY2023 | P00004 | G | $297,500.03 | — |
| May 25, 2022 | FY2022 | P00003 | M | $0.00 | — |
| Jan 7, 2022 | FY2022 | P00002 | D | $0.00 | — |
| Dec 27, 2021 | FY2022 | P00001 | C | $88,801.70 | — |
| Sep 24, 2021 | FY2021 | 0 | — | $314,114.99 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.